Also trades as: SZLS.TO (TSX) · $vol 0M
SZLSF OTC
StageZero Life Sciences Ltd.
1W: +0.0%
1M: +0.0%
3M: -80.4%
YTD: +100.0%
1Y: -80.4%
3Y: -97.8%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4M
+60.6% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$4M
+61.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2M
+64.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4M | -$3M | -$7M | -$7M | -$11M |
| Depreciation & Amort. | $311K | $298K | $216K | $509K | $437K |
| Stock-Based Comp. | $426K | $741K | $637K | $391K | $239K |
| Change in Working Capital | $339K | -$377K | -$80K | -$460K | $4M |
| Other Non-Cash Items | $1M | $634K | $209K | -$267K | $4M |
| Operating Cash Flow | -$3M | -$5M | -$3M | -$9M | -$4M |
| — Investing Activities — | |||||
| Capital Expenditures | -$3K | -$44K | -$72K | -$148K | $0 |
| Acquisitions (Net) | $0 | $11K | $0 | $81K | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | -$255 | $0 | $46K | $0 |
| Investing Cash Flow | -$3K | -$33K | -$72K | -$21K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $1M | $649K | $519K | -$388K | $290K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $2M | $0 | -$407K | $1M | $61K |
| Financing Cash Flow | $3M | $5M | $10M | $4M | $2M |
| Net Change in Cash | $65K | -$35K | $7M | -$5M | -$2M |
| Cash End of Period | $106K | $71K | $7M | $2M | $16K |
| Free Cash Flow | -$3M | -$5M | -$3M | -$9M | -$4M |